Selection criteria
- Candidate's CV: one to five points.
- Project: one to 10 points.
- Feasibility: one to five points.
EACVI Research Grant programme for 2026 - Evaluated programmes and scores
The EACVI received and reviewed 10 excellent eligible applications.
| Rank | Project | Score /20 |
|---|---|---|
| 1 | Integrating Exercise Echocardiography and Computational Modelling to Understand Cardiac Filling Dynamics in Athletes and Heart Failure: A Multi-Modal Approach |
15.571 |
| 2 | Long-term fate of the thoracic aorta and its impact on right ventricular performance and structure with Hypoplastic Left Heart Syndrome (HLHS) and Fontan Physiology | 15.429 |
| 3 | Improving the assessment of coronary disease in TAVI patients: implications of photon counting CT and Perivascular Fat Attenuation Index (FAI) | 15.000 |
| 4 | Cardiac fluid dynamics in patients with hypertrophic cardiomyopathy: towards a better understand of cardiac mechanics and risk stratification | 14.714 |
| 5 | Shear Wave Elastography in Monitoring Myocardial Stiffness in Patients with Hypertrophic Cardiomyopathy Treated with Mavacamten | 14.500 |
| 6 | Validation of Semiautomated Quantification of Mitral Valve Regurgitation post TEER by Three-Dimensional Colour Doppler Transoesophageal Echocardiography | 14.286 |
| 7 | Description of the epidemiological characteristics of Multiple and Mixed Valvular Disease patients: insight from the EACVI-MMVD study | 13.833 |
| 8 | Prevalence of coronary microvascular dysfunction assessed with quantitative cardiac magnetic resonance perfusion in women with heart failure and preserved ejection fraction and obesity | 13.429 |
| 9 | Late Gadolinium Enhancement Patterns and Comprehensive CMR Biomarkers for Risk Stratification in Multiple and Mixed Valvular Heart Disease: A Sub-Analysis of the EACVI-MMVD Study | 12.571 |
| 10 | Novel 3-dimensional echocardiographic quantification of mitral regurgitant volume | 12.571 |